Sunday 2 December 2018

Point-Of-Sale Terminals Market Expected To Trigger A Revenue Increase To USD 116.06 Billion By 2025:Key Participant Ingenico S.A., Verifone Systems


San Francisco, 03 December 2018, The global point-of-sale(POS) terminals market size is expected to reach USD 116.06 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 9.9% CAGR during the forecast period. Surge in demand for affordable wireless technologies and increasing demand for mobile POS terminals is anticipated to drive the overall market for POS terminals over the forecast period.
Introduction of chip-embedded payment cards and Personal Identification Number (PIN) has minimized security concerns relating to sensitive data theft, which is projected to drive the POS industry over the forecast period. Ubiquitous wireless connectivity, including Bluetooth, combined with availability of peripheral devices, card readers, scanners, mobile printers, and multiple platform support, is projected to drive demand over the forecast period.
In November 2016, the Indian government demonetized its economy by banning higher currency notes. It also launched the “Digital India” initiative in order to promote cashless economy and online transactions. Such changes have significantly boosted demand for POS terminals in India. Indian banks are trying to gain advantage of this demonetization by deploying large number of POS terminals in the market and providing schemes and discounts to customers in order to promote use of POS for transactions. Indian banks have surpassed the target of 1 million POS terminals post demonetization, thus supporting market growth.
There is a significant surge in demand for mPOS terminals owing to their portability and lower cost, which decreases retailers’ cost of operation and provides better reliability. These systems are now available in ultra-portable forms as well, wherein POS terminals of the size of a credit card are available in the market. Moreover, rapidly gaining popularity among end users who use their existing tablet/system as POS terminals through specialized software for their business is anticipated to fuel demand over the forecast period. These software help reduce operational cost of retailers by eliminating need to install separate hardware systems and fulfilling all the necessary needs of retailers from a POS terminal.
Cloud-based POS terminals are gaining traction mainly due to easy operation and data security that these terminals offer. Many companies are developing SaaS-based systems such as Toast, Touchbistro, and Springboard Retail in order to provide better user interface and functionality to end users.
These terminals have a range of applications, including inventory management, printing bills, payments, and carrying out loyalty programs, thus leading to increasing adoption across various end-use verticals. They offer efficient flow control, coupled with customer satisfaction, which is expected to favorably impact consumption.
Access Full Research Report On Point-Of-Sale (POS) Terminals Market Analysis:

Further key findings from the report suggest:
·         The global POS terminals market accounted for USD 47.95 billion in 2016 and is expected to expand at a CAGR of 9.9% from 2017 to 2025
·         Fixed POS emerged as the largest product segment in 2016 whereas mobile POS systems are projected to register a higher growth rate over the forecast period
·         The POS terminals services segment is anticipated to witness the highest growth at a CAGR of 11.4% between 2017 and 2025
·         North America held the largest share in the POS terminals market in 2016. On the other hand, government initiatives in countries such as India are expected to boost the market in Asia Pacific
·         Key players in the market include VeriFone Systems Inc.; Cisco Systems Inc.; Ingenico Group; and Hewlett-Packard Inc.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/communications-infrastructure-systems-and-software
Grand View Research has segmented the global POS terminals market on the basis product, component, deployment, service, application, and region:
POS Terminals Product Outlook (Revenue, USD Billion, 2014 - 2025)
·         Fixed
·         Mobile
POS Terminals Component Outlook (Revenue, USD Billion, 2014 - 2025)
·         Hardware
·         Software
·         Services
POS Terminals Deployment Outlook (Revenue, USD Billion, 2014 - 2025)
·         Cloud
·         On-premise
POS Terminals Services Outlook (Revenue, USD Billion, 2014 - 2025)
·         Managed Services
·         Repair and Maintenance services
·         Professional Services
POS Terminals Application Outlook (Revenue, USD Billion, 2014 - 2025)
·         Restaurants
·         Hospitality
·         Healthcare
·         Retail
·         Warehouse
·         Entertainment
·         Others
Point-of-Sale (POS) Terminals Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    China
o    Japan
o    South Korea
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



Thursday 29 November 2018

Point Of Care Molecular Diagnostics Market Expected To Trigger A Revenue Increase To USD USD 3.9 Billion By 2024:Key Participant Cepheid, Bio-Rad Laboratories, bioMerieux


San Francisco, 29 November 2018,  Global pointof care molecular diagnostics market is anticipated to reach USD 3.9 billion by 2024, according to a new report by Grand View Research, Inc. Ongoing research & development to miniaturize molecular diagnostics testing that provides enhanced near patient testing with high accuracy & lesser turnaround times are major factors expected to reinforce the high growth potential for POC MDx products.
Growing demand for CLIA tests that are, by definition, portable and safe enough to be used in non-laboratory settings such as pharmacy clinics, physician offices, and home-care settings, is expected to drive demand in the market over the forecast period. Ongoing research and development is continually supported and funded by a number of major international entities including the national governments of developed countries and high-value private funding agencies such as the Bill & Melinda Gates Foundation.
Furthermore, a growing portfolio of point-of-care testing capabilities that, had initially been focused on screening, testing, and diagnosis of infectious diseases in low-income developing countries, has been developing at a rapid pace over the past decade to expand its potential market to a broader range of medical faculties. Consequently, POC and molecular diagnosis tests are available and/or are under development for cardiology monitoring, oncology testing, and hematology testing.
Recent advances in the development of microfluidics and genetic sequencing instrumentation pave the way for development of cost-effective, highly accurate and rapid testing platforms, which are able to be used as true POC systems. This is a key factor that significantly contributes towards the favorably funded, high growth potential environment prevalent in the point of care molecular diagnostics market.
Access Full Research Report On Point Of Care Molecular Diagnostics Market Analysis:
www.grandviewresearch.com/industry-analysis/point-of-care-poc-molecular-diagnostics-market

Further key findings from the report suggest:
·         Application of POC MDx tests for infectious diseases accounted for over 45% of market revenue in 2015. The large share can be accounted for by the presence of an extensive portfolio of the concerned tests with a number of major market entities. Furthermore, growing disease burden of infectious diseases in developing as well as developed countries is another factor the reinforces the dominance of this segment.
·         PCR-based POC tests accounted for the largest share of the market in 2015. Widespread usage of PCR-based techniques for molecular diagnosis and commercialization of POC real time PCR products such as the cobas LIAT by Roche have provided this segment with ample opportunities for revenue generation and are expected to maintain a favorable market environment over the forecast period.
·         North America was observed to be the most lucrative region on this market and estimated to account for over 40% of the global revenue. presence of a technologically advanced medical framework, sophisticated insurance & copayment system & high R&D investment by governments and private funding organizations for the development of POC MDx tests are major factors responsible for the region’s dominant market position.
·         Key players operating in this industry include Johnson & Johnson, Danaher Corp., Cepheid, Bio-Rad Laboratories, bioMerieux, Becton Dickinson, Roche Diagnostics, Bayer Healthcare, Alere Inc (Abbott), Abbott Laboratories among others.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented point of care molecular diagnostics market on the basis of workflow, mode, services, and region:
Global Point of Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2013 - 2024)
·         Infectious Diseases
·         Oncology
·         Hematology
·         Prenatal Testing
·         Endocrinology
·         Other Applications
Global Point of Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2013 - 2024)
·         PCR-based
·         Genetic Sequencing-based
·         Hybridization-based
·         Microarray-based
Global Point of Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2013 - 2024)
·         OTC
·         POC
Global Point of Care Molecular Diagnostics End-use Outlook (Revenue, USD Million, 2013 - 2024)
·         Decentralized Labs
·         Hospitals
·         Home-care
·         Assisted Living Healthcare Facilities
·         Other uses
Point of Care Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
·         MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/